Outline Introduction:1.1 Background and Significance of Biomaterials and Nanoparticles in Tissue Engineering 1.2 Objectives and Research Questions of the Study 1.3 Structure and Methodology of the Study Fundamentals of Tissue Engineering 2.1 Principles and Goals of Tissue Engineering 2.2 Role of Biomaterials and Nanoparticles in Tissue Regeneration 2.3 Cell Biological Aspects and Tissue Development Selection Criteria for Biomaterials and Nanoparticles 3.1 Biocompatibility and Degradability 3.2 Mechanical and Physical Properties 3.3 Influence of Nanoparticles on Material Properties 3.4 Other Criteria such as Scalability and Manufacturing Costs Applications of Biomaterials and Nanoparticles in Tissue Engineering 4.1 Use in Tissue Regeneration (e.g., Bone, Skin, Cartilage) 4.2 Enhanced Drug Release and Targeted Cell Stimulation 4.3 Case Studies of Successful Applications Technological, Regulatory, and Ethical Challenges 5.1 Technological Challenges of Manufacturing and Integration 5.2 Regulatory Requirements and Approval Processes 5.3 Ethical Issues and Societal Acceptance Optimization Potentials and Future Developments 6.1 Opportunities for Improvement of Material Properties and Applications 6.2 Research Trends and New Approaches in Tissue Engineering 6.3 Perspectives for Practical Implementation and Market Introduction Summary and Conclusion 7.1 Addressing the Central Research Question 7.2 Summary of Key Findings7.3 Recommendations for Future Research and Practical ApplicationsPotential Sources: Afaq Sarah, Malik Arshi, Tarique Mohammed. (2022). Application of Nanoparticles in Tissue Engineering. Springer Singapore, 1. Auflage. eBook ISBN 978-981-16-6198-3. DOI https://doi.org/10.1007/978-981-16-6198-3
Atala Anthony, Langer Robert, Lanza Robert, Vacanti Joseph P. (2020). Principles of Tissue Engineering. Elsevier – Academic Press, 5. Auflage. eBook ISBN 978-0-128-21401-5. DOI https://doi.org/10.1016/C2018-0-03818-9
EMA. (2014). Clinical aspects related to tissue engineered products – Scientific guideline. https://www.ema.europa.eu/en/documents/scientific-guideline/reflection-paper-clinical-aspects-related-tissue-engineered-products_en.pdf
EMA. (2018). Scientific recommendation on classification of advanced therapy medicinal products. Article 17 – Regulation (EC) No 1394/2007. https://www.ema.europa.eu/en/documents/report/scientific-recommendation-classification-advanced-therapy-medicinal-products-homogenate-antlerogenic-stem-cells-tissue-engineered-product_en.pdf
FDA. (2011). Guidance for Industry Current Good Tissue Practice (CGTP) and Additional Requirements for Manufacturers of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps).
FDA. (2024). Considerations for the Use of Humanand Animal-Derived Materials in the Manufacture of Cellular and Gene Therapy and Tissue-Engineered Medical Products. Draft Guidance for Industry.
Fisher John P., Leong Kam W., Zhang lijie Grace. (2022). 3D Bioprinting and Nanotechnology in Tissue Engineering and Regenerative Medicine. Elsevier – Academic Press, 2. Auflage. eBook ISBN 978-0-128-24553-8. DOI https://doi.org/10.1016/C2020-0-01782-2
Sarvazyan, Narine. (2020). Tissue Engineering: Principles, Protocols, and Practical Exercises. Springer Cham, 1. Auflage. eBook ISBN 978-3-030-39698-5. DOI https://doi.org/10.1007/978-3-030-39698-5
Van Blitterswijk, Clemens, De Boer Jan, Uquillas Jorge Alfredo, Malik Nusrat. (2022). Tissue engineering. Elsevier – Academic Press, 3. Auflage. eBook ISBN 978-0-323-85134-3. DOI https://doi.org/10.1016/C2020-0-01481-7